Pulmonary infection with nontuberculous mycobacteria

The American Review of Respiratory Disease
M A ContrerasR S Goldstein

Abstract

Nontuberculous mycobacterial infections (NTM) are being increasingly recognized as a cause of chronic pulmonary disease. We recently reviewed the clinical, radiologic, and bacteriologic presentation of 89 adult patients ill enough to have been hospitalized between 1981 and 1985 with the diagnosis of NTM. Preexisting lung disease was present in 82% and alcohol abuse in 40%. Although M. avium complex was identified in 51% of the patients, M. xenopi, which is usually reported to occur infrequently, accounted for 38% of our cases and M. kansasii for only 9%. Treatment was limited by a high incidence of associated disease, in vitro drug resistance, drug toxicity, and a mortality rate of 32% within 18 months of admission. Nevertheless, bacteriologic conversion occurred in 29% of those treated. M. xenopi appears to be an important pathogen in southern Ontario. It differs from the other NTM by having a different pattern of in vitro drug resistance but not by its clinical or radiologic presentation.

References

Dec 1, 1974·Tubercle·D A McSwiggan, C H Collins
Jun 1, 1968·Tubercle·A Beck, J L Stanford
Dec 1, 1982·The Journal of Infectious Diseases·R C Good, D E Snider
Nov 1, 1981·Southern Medical Journal·T C KimD F Rochester
Sep 1, 1981·Reviews of Infectious Diseases·P A Jenkins
Sep 1, 1981·Reviews of Infectious Diseases·E Wolinsky

❮ Previous
Next ❯

Citations

Jul 1, 1991·European Journal of Epidemiology·S L Morris
Sep 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K SkogbergV V Valtonen
Nov 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D V Havlir
Nov 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S E Hoffner
Apr 1, 1995·Diagnostic Microbiology and Infectious Disease·C E MarxM P Weinstein
Apr 1, 1993·Seminars in Roentgenology·W T Miller, W T Miller
Jul 5, 2001·Journal of Microbiological Methods·H E Cowan, J O Falkinham
Jan 30, 2002·Bioorganic & Medicinal Chemistry·Maria Teresa CoccoAlessandro De Logu
Feb 13, 2001·Journal of Paediatrics and Child Health·A J Daley
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D P O'BrienV L Krause
Apr 8, 1998·Journal of Computer Assisted Tomography·C Wittram, G L Weisbrod
Oct 6, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Theodore K MarrasDemetris A Patsios
Jan 27, 2009·International Journal of Clinical Practice·E E McGrathUNKNOWN Infectious Diseases Society of America
Nov 16, 2002·American Journal of Respiratory and Critical Care Medicine·Kenneth N OlivierUNKNOWN Nontuberculous Mycobacteria in Cystic Fibrosis Study Group
Aug 10, 2010·American Journal of Respiratory and Critical Care Medicine·Ana Montes-WorboysVeena B Antony
Jul 16, 2008·Annals of Clinical Microbiology and Antimicrobials·Manimuthu Mani SankarSarman Singh
Jun 15, 2013·Emerging Infectious Diseases·Paul SeddonMelanie Newport
May 10, 2002·The British Journal of Radiology·C Wittram, G L Weisbrod
Jan 1, 1993·Intensive Care Medicine·J M RousseauJ P Bonsignour
Jun 17, 2006·Chest·Stephen K Field, Robert L Cowie
May 11, 2001·American Journal of Clinical Pathology·A KhoorT V Colby
May 13, 2008·The Lancet Infectious Diseases·Claudio Piersimoni, Claudio Scarparo
Dec 29, 2004·Transplantation Proceedings·E BishburgL H Arroyo
Dec 1, 1990·Tubercle·L Q TaylorS Santiago
Oct 10, 2002·Clinics in Chest Medicine·Jeffery McGarvey, Luiz E Bermudez
Oct 10, 2002·Clinics in Chest Medicine·Worakij ChalermskulratJames F Donohue
Feb 1, 1992·Journal of the American Geriatrics Society·T T Yoshikawa
May 27, 2009·Respiratory Medicine·Chun-Ta HuangUNKNOWN Tami Group
Jun 1, 1992·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S L MorrisS D Chaparas
Jun 6, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nakwon KwakJae-Joon Yim
Aug 27, 2003·Southern Medical Journal·Jihane A FaressThomas M Roy
Apr 11, 2000·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·T V Colby
Oct 30, 2007·Yonsei Medical Journal·Hye Yun ParkBum-Joon Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.